Cervical cancer is emerging as the fastest-growing cancer in Canada, presenting a troubling public health crisis that demands immediate intervention from the federal government. This urgent call to action was articulated during a press conference held by the Society of Gynecologic Oncology of Canada in Ottawa. Despite the government’s commitment in July 2025 to eradicate cervical cancer as a public health concern by 2040, experts warn that current strategies are failing to meet necessary targets.
The Alarming Statistics
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, voiced her concerns at the conference, stating, “Canada is currently facing a silent national health crisis.” In 2025 alone, approximately 1,650 Canadians were projected to receive a cervical cancer diagnosis, with around 430 succumbing to the illness, a situation Salvador described as “avoidable.”
The reliance on Pap testing has proven insufficient, alongside stagnating rates of human papillomavirus (HPV) vaccinations. Currently, only 64 per cent of Canadians complete the HPV vaccine series, which falls significantly below the threshold required for effective disease elimination. “This statistic is not just a medical failure; it is a policy failure,” she asserted, highlighting the need for a comprehensive review of existing public health strategies.
Rethinking Cervical Cancer Screening
In a bid to address these challenges, the Society of Gynecologic Oncology is advocating for a fundamental shift towards HPV DNA testing for cervical cancer screening. They propose the implementation of self-collection swabs, which would allow individuals to perform HPV testing in the comfort of their own homes. “At home swabs remove the barriers of travel, trauma history, and cultural marginalisation,” noted Dr. Salvador. This approach is especially vital for rural, Indigenous, and underserved communities, which have historically faced significant healthcare disparities.
Dr. Sarah Kean, provincial lead for cervical cancer in Manitoba, echoed these sentiments, stressing that Indigenous women experience higher rates of advanced cervical cancer due to systemic barriers. “It is due to barriers, lack of access to screening resources, geographic isolation, systemic racism in healthcare and poverty,” she explained. Kean called for robust, universal HPV screening accessible to all Canadians, emphasising that mere updates to guidelines are insufficient.
The Financial Burden of Inaction
The financial implications of cervical cancer are staggering. In 2024, the cost of treating the disease is projected to reach $132 million for the Canadian healthcare system. In contrast, screening eligible Canadians would amount to $106 million over a five-year period. The stark reality is that while other cancers in Canada are declining, cervical cancer rates are stagnating, posing an ongoing financial and health burden.
As the Canadian Cancer Society reported, cervical cancer is the fourth most diagnosed cancer and a leading cause of cancer deaths among women globally. The urgency to act is underscored by the fact that cervical cancer is one of the most preventable forms of cancer, reliant on effective vaccination, screening, and treatment access.
A Call to Action
With the World Health Organization’s global strategy to eliminate cervical cancer now in its fifth year, the stagnation in Canada’s progress is alarming. Both the nation and WHO have committed to a future free from cervical cancer, yet without significant policy changes and improved access to healthcare resources, the dream of elimination may remain just that—an unattainable dream.
Why it Matters
The escalating rates of cervical cancer in Canada signify not only a public health crisis but a pressing social justice issue as well. Marginalised communities, particularly Indigenous women, face disproportionately high risks and barriers to care. To create a fair and equitable healthcare system, Canada must prioritise comprehensive screening measures and equitable access to vaccinations. Prompt action is essential—not only to reduce the burden of cervical cancer but also to fulfil Canada’s commitment to health equity for all its citizens.
